SEATTLE — Phase Genomics, Inc., a biotech company leading advancements in next-generation sequencing (NGS) solutions for genome assembly and analysis, today announced the launch of its new platform for precision oncology. The OncoTerra platform implements a rapid, cost-effective alternative to current cytogenomic analysis tools while unlocking information in even the most challenging of sample types. […]
Partnership will Accelerate Next-Generation Sequencing into Fastest-Growing Area of Proteomics Market with Ultra-high Throughput, Ultra-high Plexity Workflow SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Proteomics Assay onto Illumina’s current and future high throughput next-generation sequencing (NGS) platforms. This partnership […]
Co-developed and co-branded products to combine market-leading proteomic and genomic analysis platforms BOULDER, Colo. — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration with Illumina, a global next-generation sequencing technology leader. The multi-year partnership agreement will bring together genomics and proteomics technology platforms in a major commercial partnership […]
BOULDER, Colo. — Inscripta, Inc., The Digital Genome Engineering Company, today announced that it has appointed Kristala Prather, PhD, to serve on its Board of Directors. Dr. Prather is currently the Arthur D. Little Professor and Executive Officer of the Department of Chemical Engineering at MIT. “We are very excited to have Kris join our board. […]
MENLO PARK, Calif. — PacBio, a leading provider of high-quality, long-read sequencing platforms, and the Care4Rare Canada Consortium (Care4Rare) announce today they are collaborating to study some of the most complex unexplained rare disease cases within Canada. Care4Rare, led out of the CHEO Research Institute affiliated with the University of Ottawa, includes 21 academic sites across […]
LOS ANGELES — Calibre Scientific is pleased to announce the acquisition of AmpliTech, a distributor of reagents and instruments to research and diagnostic laboratories with headquarters in Compiègne, France. AmpliTech further enhances Calibre Scientific’s growing distribution platform in Europe. Founded in 1996, AmpliTech specializes in molecular pathology, cytogenetics, and molecular genetics (prenatal, postnatal, and oncology). The Company […]
Accounts and funds advised by T. Rowe Price Associates, Inc. and Baillie Gifford join syndicate of investors Funding to accelerate commercial launch of revolutionary enzymatic DNA printing technology SOUTH SAN FRANCISCO, Calif., and PARIS — DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, today announced the completion of its Series C financing, […]
Illumina and Syapse Partner on Research to Evaluate Large Panel Biomarker Testing Patterns Across US Community Oncology Practices The collaboration will explore the uptake and actionability of comprehensive genomic profiling in patients with advanced cancers. San Francisco, CA – Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases […]
LAS VEGAS — GeneASIC Applied sciences might be strolling into this 12 months’s CES 2022 arm in arm with its first product, the GeneASIC Subsequent-Technology Sequencing Evaluation Acceleration Platform (NGSAAP). The annual occasion deemed probably the most influential tech occasion and is a showcase of the most recent innovation in design and engineering within the client know-how […]
The CentoCloud solution is a cloud-based Software as a Service (SaaS) platform that enables laboratories around the world to analyze, interpret, and report genomic variants, and will be able to utilize the power of proprietary reagent kits CENTOGENE is developing in collaboration with Twist Bioscience for rare disease diagnostics CentoCloud provides rapid and reliable medical […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
